Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Ms. Atena Shojaie, Kerman university of medical sciences, Iran.

Atena Shojaie is a dedicated medical-surgical nursing professional with a Master’s degree from Kerman University of Medical Sciences. Her early academic journey was marked by a passion for integrating clinical care with research, particularly in neurology and rehabilitation. Over three years of working in critical care settings, including Neurology and ICU wards, she honed her clinical expertise while also serving as a valued clinical instructor. Her research focus on guided imagery as a therapeutic intervention for multiple sclerosis and MRI-induced anxiety has led to innovative practices currently in use at major hospitals. Atena’s academic contributions are beginning to gain recognition through citations and clinical adoption of her methods.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Atena Shojaie began her journey in the field of healthcare with a strong academic foundation, earning a bachelor’s degree in nursing followed by a Master of Science in Medical-Surgical Nursing from Kerman University of Medical Sciences. Her early academic interests revolved around holistic patient care and neuro-rehabilitation, which laid the groundwork for her later clinical and research endeavors. During her postgraduate studies, she demonstrated a deep commitment to understanding patient needs—especially those facing neurological challenges—while also refining her clinical skills in hospital environments.

🏥 Professional Endeavors

In the span of just three years, Atena accumulated extensive experience working in several critical hospital wards, including Neurology, Neurosurgery, and the Intensive Care Unit (ICU). Her hands-on experience with acute and chronic conditions shaped her clinical intuition and enhanced her ability to manage complex patient cases. Parallel to her clinical work, she embraced the role of a clinical instructor, mentoring nursing and emergency medical students with a balance of academic rigor and compassionate teaching. This dual role of caregiver and educator reflects her deep-seated dedication to both practice and pedagogy.

🔬 Contributions and Research Focus

Atena’s research primarily centers on the intersection of psychological interventions and physical rehabilitation, with a particular emphasis on multiple sclerosis (MS). Her master’s thesis, “The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis,” stands as a cornerstone of her academic work. The project demonstrated measurable improvements in gait and balance among MS patients and has since influenced ongoing clinical practices. Additionally, she completed a significant study on the “Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI),” showing how guided imagery can alleviate pre-procedure stress—further reflecting her commitment to patient-centered innovations.

🧠 Innovations in Mental Imagery

Atena Shojaie has been instrumental in translating academic research into practical tools for patient care. One of her notable innovations includes the creation of a guided imagery audio file, which is now regularly used in two major healthcare centers—Bahonar Hospital’s MRI department and Shafa Hospital’s MS Clinic. This therapeutic tool has not only improved the mental well-being of patients but also contributed to smoother clinical workflows, particularly in high-anxiety environments like radiology units.

📈 Impact and Influence

Although still early in her research career, Atena’s work has begun to gain scholarly recognition. With a citation index that includes three citations and an h-index of 1, her research is already laying the foundation for future studies in neuro-nursing and psychological rehabilitation. Her work continues to resonate with clinical teams and academics alike, especially those focused on non-pharmacological interventions for neurological conditions.

🏅 Accolades and Recognition

Atena’s clinical and research activities have earned her respect among her peers and mentors at Kerman University of Medical Sciences. While formal awards may still be on the horizon, her true recognition lies in the adoption of her guided imagery methods by major hospitals—an endorsement of both her scientific rigor and clinical insight. Her role as a trusted clinical instructor further affirms her reputation as a knowledgeable and compassionate professional.

🌟 Legacy and Future Contributions

With a solid foundation in research and hands-on care, Atena Shojaie is poised to make enduring contributions to the field of neuro-rehabilitative nursing. Her vision includes expanding the use of therapeutic mental imagery in broader hospital settings and conducting multi-center studies to further validate its effectiveness. As she continues her academic and clinical journey, her legacy will likely be defined by a thoughtful fusion of science, compassion, and innovation—paving the way for future advancements in holistic patient care.

Publication

 

  • Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI): The Effectiveness of Guided Mental Imagery
    Authors: A. Shojaie, H. Amiri, T. Dehesh, B. Bagherian
    Year: 2024

 

  • The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis: A Randomized Controlled Trial
    Authors: B.B. Atena Shojaie, Hoda Kamali, Monir Sadat Nematollahi, Zahra Imani Goghary
    Year: 2025

 

✅ Conclusion

Atena Shojaie exemplifies the new generation of nurse-researchers who bridge the gap between evidence-based practice and compassionate patient care. Her work in guided mental imagery not only addresses physical dysfunction but also supports patients’ emotional and psychological needs. As she continues to expand her research and clinical impact, Atena is well-positioned to influence future standards in neuro-nursing and non-pharmacological therapy. Her legacy will likely be defined by innovation, empathy, and a relentless pursuit of better outcomes for patients with neurological conditions.

Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotilde’s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

 

🎓 Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

🧠 Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

🔬 Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

🏅 Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017–2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the Società Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentation—an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

🌍 Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

🧬 Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

📚 Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual base—rooted in Italy and expanding into the United States—places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

  • Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis

  • Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.

  • Year: 2024

 

📝 Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health care—building a legacy rooted in evidence, empathy, and innovation.

 

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.

 

Jin Yong Hong | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Jin Yong Hong | Behavioral Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Jin Yong Hong,  Yonsei University Wonju College of Medicine,  South Korea.

Dr. Jin Yong Hong, MD, PhD, is a distinguished neurologist and academic leader with a career grounded in excellence, innovation, and service. Beginning his medical education at Yonsei University, he steadily advanced through rigorous academic and clinical pathways to become an Associate Professor at Yonsei University Wonju College of Medicine. His focused expertise in movement disorders and dementia, enriched by both national and international research experience, especially at the University of Pennsylvania, highlights his dedication to solving complex neurological diseases. Through teaching, research, and clinical practice, he has significantly contributed to the growth of neuroscience and medical education in South Korea.

 

Profile

Google Scholar

Orcid

 

🎓 Early Academic Pursuits

Dr. Jin Yong Hong embarked on his journey in medicine with a deep commitment to academic excellence, beginning with his premedical studies at Yonsei University in Seoul from 2001 to 2003. He swiftly advanced through the rigorous medical curriculum, earning a Bachelor of Medical Science in 2007. Not content with just clinical practice, he pursued higher education with a Master of Medical Science completed in 2014 and culminated his scholarly journey with a Doctorate in Medical Science from the same esteemed institution in 2021. His academic path reflects a relentless pursuit of knowledge in the neurological sciences and a strong foundation in research methodology and clinical application.

🧠 Professional Endeavors in Neurology

Following his graduation, Dr. Hong immersed himself in hands-on clinical training, beginning with an internship and residency in Neurology at the renowned Severance Hospital of the Yonsei University Health System. This period, from 2007 to 2012, was marked by rigorous clinical immersion and specialization. His passion for neuroscience led him to pursue subspecialty training in Movement Disorders and Dementia, completing both clinical and research fellowships. Notably, he expanded his research exposure internationally through a postdoctoral fellowship at the University of Pennsylvania in the United States from 2022 to 2024, further enriching his expertise in neurodegenerative pathology and laboratory medicine.

🔬 Contributions and Research Focus

Dr. Hong’s research has consistently revolved around movement disorders and dementia, placing him at the forefront of understanding neurodegenerative diseases. His clinical experience, paired with extensive research work in both Korea and the United States, underscores his commitment to unraveling the complexities of disorders like Parkinson’s disease, Alzheimer’s disease, and related cognitive impairments. His interdisciplinary approach bridges clinical neurology with translational science, contributing significantly to advancing diagnostic and therapeutic strategies in the field.

🏥 Academic Leadership and Teaching

As an Associate Professor at the Department of Neurology, Yonsei University Wonju College of Medicine, Dr. Hong plays a vital role in shaping the next generation of neurologists. Since 2016, he has not only led clinical initiatives but also mentored students and junior faculty. His previous tenure as a Clinical Assistant Professor from 2014 to 2016 helped lay the groundwork for a collaborative and research-driven academic environment at the Wonju Severance Christian Hospital. His academic roles have helped blend clinical excellence with cutting-edge research in one of Korea’s premier medical institutions.

🏅 Accolades and Recognition

Dr. Hong’s excellence has been consistently recognized by peers and institutions alike. In 2014, he received the Academic Award for Highest Achievement from Yonsei University College of Medicine, marking him as a top-tier scholar among his peers. The same year, he was awarded a Fellowship by the Korean Movement Disorder Society, acknowledging his promising contributions to the field. Further cementing his role as a leading voice in neurological research, he was honored in 2021 with the JMD Article Award, reflecting the impact and relevance of his scholarly publications.

🌍 Impact and Influence in Neurological Science

With active memberships in the Korean Neurological Association, the Korean Movement Disorder Society, and the Korean Dementia Association, Dr. Hong maintains an influential presence within the scientific community. His cross-continental experience, especially through his postdoctoral work in the United States, has positioned him as a bridge between Eastern and Western neurological research paradigms. His publications and ongoing collaborations continue to influence both clinical practice and academic discourse, especially in the diagnosis and management of neurodegenerative conditions.

🌟 Legacy and Future Contributions

Looking ahead, Dr. Jin Yong Hong is poised to continue making groundbreaking contributions in the field of neurology. With a career marked by academic distinction, clinical expertise, and research innovation, he represents a model of holistic excellence in medicine. His future work is likely to delve deeper into translational neuroscience, aiming to develop practical solutions for patients suffering from movement and cognitive disorders. As a mentor, researcher, and clinician, Dr. Hong is building a legacy that will inspire and influence the medical community for years to come.

Publication

  • Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson’s disease
    S Shin, JE Lee, JY Hong, MK Sunwoo, YH Sohn, PH Lee
    2012

 

  • Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
    JY Hong, JS Oh, I Lee, MK Sunwoo, JH Ham, JE Lee, YH Sohn, JS Kim, …
    2014

 

  • The MMSE and MoCA for screening cognitive impairment in less educated patients with Parkinson’s disease
    JI Kim, MK Sunwoo, YH Sohn, PH Lee, JY Hong
    2016

 

  • The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson’s disease
    MK Sunwoo, S Jeon, JH Ham, JY Hong, JE Lee, JM Lee, YH Sohn, …
    2014

 

  • Cerebral microbleeds in patients with Parkinson’s disease
    JH Ham, H Yi, MK Sunwoo, JY Hong, YH Sohn, PH Lee
    2014

 

  • Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson’s disease
    JY Hong, MK Sunwoo, SJ Chung, JH Ham, JE Lee, YH Sohn, PH Lee
    2014

 

  • Clinical and biomarker characteristics according to clinical spectrum of Alzheimer’s disease (AD) in the validation cohort of Korean Brain Aging Study for the Early Diagnosis …
    J Hwang, JH Jeong, SJ Yoon, KW Park, EJ Kim, B Yoon, JW Jang, HJ Kim, …
    2019

 

  • Subjective cognitive complaints and objective cognitive impairment in Parkinson’s disease
    JY Hong, Y Lee, MK Sunwoo, YH Sohn, PH Lee
    2018

 

  • Neurocognitive and atrophic patterns in Parkinson’s disease based on subjective memory complaints
    JY Hong, JE Lee, YH Sohn, PH Lee
    2012

 

  • Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease
    SH Koh, SH Choi, JH Jeong, JW Jang, KW Park, EJ Kim, HJ Kim, JY Hong, …
    2020

 

🧾 Conclusion

Dr. Hong’s journey illustrates the profound impact one dedicated individual can make within the scientific and medical communities. His legacy is already evident in his scholarly achievements, the students he mentors, and the patients he serves. As he continues to advance the understanding and treatment of neurological conditions, Dr. Hong remains a beacon of academic integrity, scientific rigor, and compassionate care. His future promises continued breakthroughs that will shape the field of neurology and bring hope to countless lives affected by neurodegenerative disorders.